Novel drug resistance pattern associated with the mutations K70G and M184V in human immunodeficiency virus type 1 reverse transcriptase

被引：10
|
作者：
Bradshaw, D.
Malik, S.
Booth, C.
Van Houtte, M.
Pattery, T.
Waters, A.
Ainsworth, J.
Geretti, A. M.
机构：
[1] Royal Free Hosp, Dept Virol, London NW3 2QG, England
[2] UCL, Sch Med, Royal Free Hosp, London W1N 8AA, England
[3] Virco BVBA, Mechelen, Belgium
[4] N Middlesex Hosp, Dept HIV Med, London, England
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 12期
关键词：
D O I：
10.1128/AAC.00687-07
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We describe an unusual pathway of human immunodeficiency virus type 1 reverse transcriptase resistance during therapy with tenofovir-emtricitabine, characterized initially by the mutations K70E and M184V and later by K70G and M184V, with the two mutations coexisting on the same viral genome. Phenotypic resistance to lamivudine, emtricitabine, abacavir, didanosine, and tenofovir was observed, whereas susceptibility to zidovudine and stavudine was preserved.
引用
收藏
页码：4489 / 4491
页数：3
相关论文
共 50 条
  • [21] Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1
    Hsu, ML
    Inouye, P
    Rezende, L
    Richard, N
    Li, Z
    Prasad, VR
    Wainberg, MA
    NUCLEIC ACIDS RESEARCH, 1997, 25 (22) : 4532 - 4536
  • [22] Reversion of the M184V mutation in simian immunodeficiency virus reverse transcriptase is selected by tenofovir, even in the presence of lamivudine
    Murry, JP
    Higgins, J
    Matthews, TB
    Huang, VY
    Van Rompay, KKA
    Pedersen, NC
    North, TW
    JOURNAL OF VIROLOGY, 2003, 77 (02) : 1120 - 1130
  • [23] A Role of Template Cleavage in Reduced Excision of Chain-Terminating Nucleotides by Human Immunodeficiency Virus Type 1 Reverse Transcriptase Containing the M184V Mutation
    Acosta-Hoyos, Antonio J.
    Matsuura, Suzanne E.
    Meyer, Peter R.
    Scott, Walter A.
    JOURNAL OF VIROLOGY, 2012, 86 (09) : 5122 - 5133
  • [24] Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors
    Svicher, Valentina
    Sing, Tobias
    Santoro, Maria Mercedes
    Forbici, Federica
    Rodriguez-Barrios, Fatima
    Bertoli, Ada
    Beerenwinkel, Niko
    Bellocchi, Maria Concetta
    Gago, Federigo
    Monforte, Antonella d'Arminio
    Antinori, Andrea
    Lengauer, Thomas
    Ceccherini-Silberstein, Francesca
    Perno, Carlo Federico
    JOURNAL OF VIROLOGY, 2006, 80 (14) : 7186 - 7198
  • [25] In vitro selection of mutations in human immunodeficiency virus type 1 reverse transcriptase that confer resistance to capravirine, a novel nonnucleoside reverse transcriptase inhibitor
    Sato, Akihiko
    Hammond, Jennifer
    Alexander, Therese N.
    Graham, Joanne P.
    Binford, Susan
    Sugita, Ken-ichi
    Sugimoto, Hirohiko
    Fujiwara, Tamio
    Patick, Amy K.
    ANTIVIRAL RESEARCH, 2006, 70 (02) : 66 - 74
  • [26] Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance
    Xu, Hong-Tao
    Martinez-Cajas, Jorge L.
    Ntemgwa, Michel L.
    Coutsinos, Dimitrios
    Frankel, Fernando A.
    Brenner, Bluma G.
    Wainberg, Mark A.
    RETROVIROLOGY, 2009, 6
  • [27] Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance
    Hong-Tao Xu
    Jorge L Martinez-Cajas
    Michel L Ntemgwa
    Dimitrios Coutsinos
    Fernando A Frankel
    Bluma G Brenner
    Mark A Wainberg
    Retrovirology, 6
  • [28] Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity
    White, KL
    Margot, NA
    Wrin, T
    Petropoulos, CJ
    Miller, MD
    Naeger, LK
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3437 - 3446
  • [29] Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase
    Zhang, Zhijun
    Walker, Michelle
    Xu, Wen
    Shim, Jae Hoon
    Girardet, Jean-Luc
    Hamatake, Robert K.
    Hong, Zhi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (08) : 2772 - 2781
  • [30] Neutralizing antibodies directed against the V3 loop select for different escape variants in a virus with mutated reverse transcriptase (M184V) than in wild-type human immunodeficiency virus type 1
    Inouye, P
    Cherry, E
    Hsu, M
    Zolla-Pazner, S
    Wainberg, MA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (09) : 735 - 740
12345